GLOBAL PRICING POLICIES AND COST-EFFECTIVENESS OF TRASTUZUMAB IN LATIN AMERICA

被引:0
|
作者
Giffin, Robert B. [1 ]
机构
[1] Medtronic, Minneapolis, MN 55432 USA
关键词
Compilation and indexing terms; Copyright 2024 Elsevier Inc;
D O I
10.1017/S026646231500029X
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:1 / 1
页数:1
相关论文
共 50 条
  • [31] The cost-effectiveness of five policies for improving student achievement
    Yeh, Stuart S.
    AMERICAN JOURNAL OF EVALUATION, 2007, 28 (04) : 416 - 436
  • [32] Emissions Pricing, "Complementary Policies" and "Direct Action" in the Australian Electricity Supply Sector: Some Conditions for Cost-Effectiveness
    Naughten, Barry
    ECONOMIC PAPERS, 2013, 32 (04): : 440 - 453
  • [33] The global impact and cost-effectiveness of a melioidosis vaccine
    Nantasit Luangasanatip
    Stefan Flasche
    David A. B. Dance
    Direk Limmathurotsakul
    Bart J. Currie
    Chiranjay Mukhopadhyay
    Tim Atkins
    Richard Titball
    Mark Jit
    BMC Medicine, 17
  • [34] The Role of Cost-Effectiveness Analysis in Global Anesthesia
    Kassebaum, Nicholas J.
    McQueen, Kelly
    ANESTHESIA AND ANALGESIA, 2018, 126 (04): : 1397 - 1399
  • [35] The global impact and cost-effectiveness of a melioidosis vaccine
    Luangasanatip, Nantasit
    Flasche, Stefan
    Dance, David A. B.
    Limmathurotsakul, Direk
    Currie, Bart J.
    Mukhopadhyay, Chiranjay
    Atkins, Tim
    Titball, Richard
    Jit, Mark
    BMC MEDICINE, 2019, 17
  • [36] A THEORY ON ICER PRICING AND OPTIMAL LEVEL OF COST-EFFECTIVENESS THRESHOLD
    Berdud, M.
    Ferraro, J.
    Towse, A.
    VALUE IN HEALTH, 2020, 23 : S301 - S302
  • [37] TRASTUZUMAB IN METASTATIC BREAST CANCER: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES
    Andrade, T. S. D.
    Mosegui, G. B. G.
    Miranda, E. S.
    Souza, T. F. G. D.
    Vianna, C. M. D. M.
    Silva, F. V. C.
    VALUE IN HEALTH, 2013, 16 (07) : A687 - A687
  • [38] Cost-effectiveness analysis of adjuvant therapy with trastuzumab for early breast cancer
    Wardley, Andrew M.
    Cameron, David A.
    Bell, Richard
    Erny, Samuel
    Cohen, Carole
    Geary, Una
    Walzer, Stefan
    Gyldmark, Marlene
    ANNALS OF ONCOLOGY, 2006, 17 : 95 - 96
  • [39] THE THRESHOLD PRICING MODEL: NOT JUST ANOTHER COST-EFFECTIVENESS MODEL
    Mladsi, D.
    Earnshaw, S.
    Akashi-Ronquest, N.
    Keith, M. S.
    VALUE IN HEALTH, 2010, 13 (07) : A332 - A332
  • [40] PATENT EXPIRY AND GENERIC PRICING: THE IMPACT ON COST-EFFECTIVENESS RESULTS
    Hirst, A.
    Murphy, D.
    Vlachaki, I
    VALUE IN HEALTH, 2015, 18 (07) : A703 - A703